The role of epidermal growth factor (EGF) and its receptor in mucosal protection, adaptation to injury, and ulcer healing: Involvement of EGF-R signal transduction pathways

Journal of Clinical Gastroenterology

Volumn 27, Issue SUPPL. 1, 1998, Pages

  Tarnawski, Andrzej S ^a   Jones, Michael K ^b  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

EGF; Gastric ulcer; Growth factors; Healing; Helicobacter pylori

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE;

CONFERENCE PAPER; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH MUCOSA; STOMACH MUCOSA INJURY; STOMACH PROTECTION; STOMACH ULCER; ULCER HEALING; ULCEROGENESIS;

EPIDERMAL GROWTH FACTOR; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STOMACH ULCER; WOUND HEALING;

EID: 0032429008     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-199800001-00004     Document Type: Conference Paper

References (63)

1. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 1962;237:1555-62.
2. Gregory H. Isolation and structure of urogastrone and its relationship to epidermal growth factor. Nature 1975;257: 325-7.
3. Brown KD. The epidermal growth factor/transforming growth factor-α family and their receptors. Eur J Gastroenterol Hepatol 1995;7:914-22.
4. Boonstra J, Rijken P, Humbel B, Cremers F, Verkleij A, en Heneouwen PvB. The epidermal growth factor. Cell Biol Int 1995;19:413-30.
5. Pimental E. Epidermal growth factor. In: Pimental E, ed. Handbook of growth factors. Vol. II. Peptide growth factor. Boca Raton, FL: CRC Press, 1994:97-202.
6. Podolsky DK. Peptide growth factors in the gastrointestinal tract. In: Johnson LR, ed. Physiology of the GI tract. Vol. 1. 3rd ed. New York: Raven Press, 1994:129-67
7. Konturek SJ. Role of growth factors in gasdtroduodenal protection and healing of peptic ulcer. Gastroenterol Clin North Am 1990;19:41-65.
8. Konturek PC, Konturek SJ, Brzozowski T, Ernst H. Epidermal growth factor and transforming growth factor-α: role in protection and healing of gastric mucosal lesions. Eur J Gastroenterol Hepatol 1995;7:933-8.
9. Beauchamp RD, Barnard JA, McCutchen CM, Cherner JA, Coffey RJ. Localization of transforming growth factor α and its receptor in gastric mucosal cells: implication for α regulatory role in acid secretion and mucosal renewal. J Clin Invest 1989;84:1017-23.
10. Ishikawa T, Fukuda T, Sugiyama M, Tarnawski A. Direct protective action of epidermal growth factor on isolated gastric mucosal surface epithelial cells. J Physiol Pharmacol 1992; 43:323-32.
11. Ishikawa T, Sarfeh IJ, Tarnawski A, Golshan R, Douglass T, Sugiyama M. Epidermal growth factor protects portal hypertensive gastric mucosa ischemia/reperfusion: the role of capillary endothelia and prostaglandins. Surgery 1992;112:341-6.
12. Ishikawa T, Tarnawski A, Sarfeh IJ, Stachura J. Epidermal growth factor protects gastric mucosa against ischemiareperfusion injury. J Clin Gastroenterol 1993;17(suppl 1): S104-10.
13. Goodlad RA, Wright NA. Epidermal growth factor and transforming growth factor-α actions on the gut. Eur J Gastroenterol Hepatol 1995;7:928-32.
14. Sasaki E, Pai R, Komurasaki T, et al. Induction of cyclooxygenase-2 in rat gastric epithelial cell line by epiregulin and basic fibroblast growth factor. Journal of Clinical Gastroenterology 1998;27(suppl 1):S21-27.
15. Ivey KJ, Tarnawski A, Stachura J, Werner H, Mach T, Burks M. The induction of gastric mucosa tolerance to alcohol by chronic administration. J Lab Clin Med 1980;96:922-32.
16. Tarnawski A, Lu S-Y, Stachura J, Sarfeh IJ. Adaptation of gastric mucosa to chronic alcohol administration is associated with increased mucosal expression of growth factors and their receptor. Scand J Gastroenterol 1992;27(suppl 193):59-63.
17. Konturek SJ, Konturek JW. Gastric adaptation: basic and clinical aspect. Digestion 1994;55:131-8.
18. Coffey RJ, Gangarosa LM, Damstrup L, Dempsey PJ. Basic actions of transforming growth factor-α and related peptides. Eur J Gastroenterol Hepatol 1995;7:923-7.
19. Tarnawski A, Stachura J, Krause WJ, Douglass T, Gergely H. Quality of gastric ulcer healing: a new emerging concept. J Clin Gastroenterol 1991;13:S42-7.
20. Tarnawski A. Cellular mechanism of gastric ulcer healing. In: Domschke W, Konturek SJ, eds. The stomach. Berlin: Springer-Verlag, 1993:177-92.
21. Skov Olsen P, Poulsen SS, Therkelsen K, Nexo E. Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcer in rats. Gastroenterology 1986; 90:911-7.
22. Guglietta A, Sulliva PB. Clinical applications of epidermal growth factor. Eur J Gastroenterol Hepatol 1995;7:945-50.
23. Konturek SJ, Dembinski A, Warzecha T, et al. Role of epidermal growth factor in healing of chronic gastroduodenal ulcer in rats. Gastroenterology 1986;94:1300-7.
24. Itoh M, Joh T, Imai S, et al. Experimental and clinical studies on epidermal growth factor for gastric mucosal protection and healing of gastric ulcers. J Clin Gastroenterol 1988;10(suppl 1):S7-12.
25. Olsen PS, Poulsen SS, Therkelsen K, et al. Effects of sialoadenectomy and synthetic human urogastrone on healing of chronic gastric ulcers in rats. Gut 1986;27:1443-9.
26. Wright NA, Pike C, Elia G. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990;343:82-5.
27. Tarnawski A, Stachura J, Durbin T, Sarfeh IJ, Gergely H. Increased expression of epidermal growth factor receptor during gastric ulcer healing in rats. Gastroenterology 1992;102: 695-8.
28. Lee H, Hansson H-A, Norstrom E, Helander HF. Immunoreactivities for epidermal growth factor (EGF) and for EGF receptors in rats with gastric ulcer. Cell Tissue Res 1991;265: 211-8.
29. Tarnawski A, Wahlstrom K, Nguyen T, Sarfeh IJ. Treatment with hydrotalcit activates gastric mucosal genes encoding for EGF, bFGF and FGF receptor. The molecular basis for its ulcer healing action [Abstract]. Gut 1995;37(suppl 2):A81.
30. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD, eds. Cell signaling. In: Molecular biology of the cell. 3rd ed. New York: Garland Publishing, 1994:721-34.
31. Lemmon MA, Schlessinger J. Regulation of signal-transduction and signal diversity by receptor oligomerization. Trends Biochem Sci 1994;19:459-63.
32. Heldin CH. Dimerization of cell-surface receptors in signal-transduction. Cell 1995;80:213-23.
33. Marshall CJ. Specificity of receptor tyrosine kinase signalling - transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-85.
34. van der Geer P, Hunter T, Lindberg RA. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu Rev Cell Biol 1994;10:251-337.
35. Schlessinger J. SH2/SH3 signaling proteins. Curr Opin Genet Dev 1994;4:25-30.
36. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993;268:14553-6.
37. Crew CM, Erikson RI. Extracellular signals and reversible protein phosphorylation: what to make of it all? Cell 1993;74: 215-7.
38. Wither DJ. Signalling pathways involved in the mitogenic effects of cAMP. Clin Sci 1997;92:445-51.
39. Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science 1993;262:1069-72.
40. Shuai K, Ziomiecki A, Wilks AF, et al. Polypeptide signalling to the nucleus through tyrosine phosphorylation of Jak and Stat proteins. Nature 1993;366:580-3.
41. Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994;265: 95-8.
42. de Groot RP, Rijken PJ, Boonstra J, Verkleij AJ, de Latt SW, Kruijer W. Epidermal growth factor induced expression of c-fos influenced by altered gravity conditions. Aviat Space Environ Med 1991;62:37-40.
43. Rijken PJ, Hag WJ, van Bergen, en Henegouwen PMP, Verkleij AJ, Boonstra J. Epidermal growth factor induces rapid reorganization of the actin microfilament system in human A431 cells. J Cell Sci 1991;100:491-9.
44. Hall A. Ras-related GTPase and cytoskeleton. Mol Biol Cell 1992;3:471-9.
45. Wennstrom S, Siegbahn A, Yokote K, et al. Membrane ruffing and chemotaxis transduced by the PDGF β-receptor require the binding site for phosphatidylinositol 3′ kinase. Oncogene 1994;9:651-60.
46. van Bergen en Henegouwen PMP, den Hartigh JC, Romeijn P, Verkleij AJ, Boonstra J. The epidermal growth factor is associated with actin filaments. Exp Cell Res 1992;199:90-7.
47. den Hartigh JC, van Bergen en Henegouwen PMP, Verkleij AJ, Boonstra J. The EFG receptor is an actin-binding protein. J Cell Biol 1992;119:349-55.
48. Relan NK, Fligiel SEG, Dutta S, Tureaud J, Chauhan DP, Majumdar AP. Induction of EGF-receptor tyrosine kinase during early reparative phase of gastric mucosa and effects of aging. Lab Invest 1996;73:717-26.
49. Majumdar AP, Fligiel SEG, Jaszewski R, Tureaud J, Dutta S, Dhelluderai B. Inhibition of gastric mucosal regeneration by tryphostin: evaluation of the role of epidermal growth factor receptor tyrosine kinase. J Lab Clin Med 1996;128:173-80.
50. Goke M, Kanai M, Podolsky DK. Repair of wounded intestinal epithelium is mediated by MAP kinase signaling pathways induced by TGFα [Abstract]. Gastroenterology 1997; 112:A981.
51. Dieckgraefe BK, Weems DM. Identification of gastrointestinal epithelial wound-induced signaling pathway [Abstract]. Gastroenterology 1997;112:A359.
52. Pai R, Itani RM, Ohta M, Sarfeh IJ, Tarnawski A. Molecular mechanisms of experimental gastric ulcer healing: role of tyrosine kinase, EGF-R, MAP, kinases and c-fos [Abstract]. Gastroenterology 1997;112:A250.
53. Pai R, Ohta M, Itani RM, Sarfeh IJ, Tarnawski AS. Induction of mitogen activated protein kinase signal transduction pathway during gastric ulcer healing in rat model. Gastroenterology 1998;114:706-13.
54. NIH Consensus Conference. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv Intern Med 1996;41:85-119.
55. Labenz J, Borsch G. Highly significant change of the clinical course of relapsing and complicated peptide ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994;89:1785-8.
56. Wyle F, Chang KJ, Stachura J, Tarnawski A. Helicobacter pylori cytotoxin and the healing of experimental gastric ulcer. Eur J Gastroenterol Hepatol 1993;5:S75-9.
57. Fujiwara Y, Wyle F, Arakawa T, et al. Helicobacter pylori culture supernatant inhibits binding and proliferative response of human gastric cell to epidermal growth factor: Implications for H. pylori interference with ulcer healing? Digestion 1997;58:299-303.
58. Pai R, Wyle FA, Cover TL, Itani RM, Domek M, Tarnawski A. H. pylori culture supernatant interferes with epidermal growth factors-activated signal transduction in human gastric Kato III cells. Am J Pathol 1998;152:1617-24.
59. Akagi M, Yokozaki H, Kitadai Y, et al. Expression of amphiregulin in human gastric cancer cell lines. Cancer 1995;75: 1460-6.
60. Naef M, Yokoyama M, Friess H, Buechler MW, Korc M. Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int J Cancer 1996;66:315-21.
61. Abe S, Sasano H, Katoh K, et al. Immunohistochemical studies on EGF family growth factors in normal and ulcerated human gastric mucosa. Dig Dis Sci 1997;42:1199-209
62. Murayama Y, Miyagawa J, Higashiyama S, et al. Localization of heparin-binding epidermal growth factor-like growth factor in human gastric mucosa. Gastroenterology 1995;198:1051-9.
63. Tsutsui S, Shinomura Y, Higashiyama S, et al. Induction of heparin binding epidermal growth factor-like growth factor and amphiregulin mRNAs by gastrin in the rat stomach. Biochem Biophys Res Commun 1997;235:520-3.